|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.840 USD | +0.29% |
|
-6.03% | -13.82% |
Company Valuation: DiaMedica Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 124.8 | 56.55 | 142.3 | 334.1 | 568.4 | 517.9 | - | - |
| Change | - | -54.69% | 151.72% | 134.69% | 70.13% | -8.89% | - | - |
| Enterprise Value (EV) | 124.8 | 56.55 | 142.3 | 334.1 | 568.4 | 517.9 | 517.9 | 517.9 |
| Change | - | -54.69% | 151.72% | 134.69% | 70.13% | -8.89% | 0% | 0% |
| P/E | -5.74x | -3.04x | -4.73x | -9.05x | -11.4x | -8.22x | -7.75x | -6.69x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | -0.3x | - | -0.7x | -0.4x | -1.29x | -0.4x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 82.1x |
| EV / Revenue | - | - | - | - | - | - | - | 82.1x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -8.36x | -7.86x | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.98x | -6.53x | -4.93x |
| EV / FCF | - | - | - | -0x | -0x | -8.15x | -6.35x | -5.66x |
| FCF Yield | - | - | - | -9.45% | -7.15% | -12.3% | -15.7% | -17.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.65 | -0.52 | -0.6 | -0.6 | -0.7 | -0.83 | -0.88 | -1.02 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 6.309 |
| EBITDA 1 | - | - | -28.81 | -38.06 | -47.83 | -61.92 | -65.88 | - |
| EBIT 1 | -17.41 | -19.07 | -28.85 | -38.12 | -47.89 | -64.93 | -79.27 | -105 |
| Net income 1 | -17.34 | -18.63 | -26.3 | -34.92 | -45.62 | -63.21 | -78.02 | -103.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.730 | 1.580 | 2.840 | 5.430 | 7.960 | 6.820 | 6.820 | 6.820 |
| Nbr of stocks (in thousands) | 26,439 | 26,443 | 37,954 | 42,761 | 52,077 | 53,883 | - | - |
| Announcement Date | 3/14/22 | 3/28/23 | 3/19/24 | 3/17/25 | 3/30/26 | - | - | - |
1CAD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.22x | - | - | - | 367M | |
| 21.08x | 6.49x | 14.2x | 1.51% | 55.92B | |
| 33.57x | 8.33x | 25.41x | 0.06% | 56.67B | |
| -18.45x | 4.44x | -7.77x | -.--% | 23.28B | |
| -42.05x | 13.36x | -39.35x | -.--% | 23.28B | |
| 25.7x | 5.07x | 13.38x | -.--% | 20.54B | |
| 24.87x | 4.83x | 15.68x | -.--% | 17.78B | |
| -617.89x | 37.85x | -1571.42x | -.--% | 15.9B | |
| 44.16x | 17.85x | 45.97x | 0.08% | 14.64B | |
| 17.51x | 5.07x | 11.83x | -.--% | 13.99B | |
| Average | -51.97x | 11.48x | -165.79x | 0.18% | 24.24B | |
| Weighted average by Cap. | -25.96x | 9.81x | -92.78x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DMAC Stock
- Valuation DiaMedica Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
